Anti-KIRD2 Subgroup Recombinant Antibody (Lirilumab) (CAT#: TAB-757)
Recombinant human monoclonal antibody expressed in CHO binding to human KIRD2 subgroup. Lirilumab is a human monoclonal antibody designed for the treatment of cancer.
Specific Inquiry
ELISA
Figure 1 Anti-KIRD2 Subgroup Antibody (Lirilumab) (TAB-757) in ELISA
ELISA analysis of TAB-757 was performed by coating with KIR2DL1 Protein, Human, Recombinant (His Tag).
Blue line: TAB-757
Red line: Negative control
SDS-PAGE
Figure 2 Anti-KIRD2 Subgroup Recombinant Antibody (TAB-757) in SDS-PAGE
SDS-PAGE analysis of TAB-757 in non-reduced (Lane 1) and reduced (Lane 2) conditions.
SEC-HPLC
Figure 3 Anti-KIRD2 Subgroup Recombinant Antibody (TAB-757) in HPLC
HPLC analysis of TAB-757 shows the purity is>95%.
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Human
- Type
- IgG4 - kappa
- Species Reactivity
- Human
- Applications
- Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, ICC and most other immunological methods.
- CAS
- 1000676-41-4
- Generic Name
- lirilumab
- MW
- 145.2 kDa
- Related Disease
- Acute myeloid leukemia (AML)
Product Property
- Purity
- >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
- Storage
- Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C.
Target
- Alternative Names
- lirilumab;1000676-41-4;IPH 2101;IPH2101;1-7F9;IPH 2102;IPH2102;BMS-986015;Killer-cell immunoglobulin-like receptors;KIRs;KIR2DL1/2/3
Related Resources
Please refer to Lirilumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Lirilumab.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Lirilumab"
Afuco™ Anti-KIRD2 ADCC Recombinant Antibody (Lirilumab), ADCC EnhancedThis product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to human KIRD2 subgroup. Lirilumab is a human monoclonal antibody designed for the treatment of cancer.
See other products for "KIRD2"
Select a product category from the dropdown menu below to view related products.
Please select product type
Single-domain Antibody
| CAT | Product Name | Application | Type |
|---|---|---|---|
| NAB-1602-sdAb | Recombinant Anti-Human KIRD2 VHH Single Domain Antibody | WB, ICC, ChiP, FA, ELISA | Llama VHH |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for TAB-757. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: Neut, ELISA, IF, IP, FuncS, FC, IHC
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: ELISA, IP, FC, FuncS, Neut, IF, IHC
Application: ELISA, IHC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: FC, IHC, Cyt, FuncS
Application: ELISA, WB, Microarray, Block
Application: ELISA, Cyt, PP, Inhib
Application: ELISA, Neut, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
